ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.

Jacobi B Hines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.